Stage I NSCLC

Study Question: Is there an improvement in local control rates for patients with early stage non-small cell lung cancer treated with stereotactic body radiotherapy compared to conventional radiotherapy?

OLIGOMETASTATIC NSCLC

Study Question: Can stereotactic ablative radiotherapy lead to improvements in overall survival and quality of life in selected patients with oligometastatic disease compared to current approaches of chemotherapy and conventional radiotherapy?